The Flow Cytometry Core Facility (FCCF) at H. Lee Moffitt Cancer Center &Research Institute was established in 1990 to provide a centralized flow cytometry service for Cancer Center members and University of South Florida faculty with cancer related research interests. Flow cytometry is an indispensable analytical tool for cell biology, immunology, and translational research efforts at the Cancer Center. This technology provides a means for rapidly and accurately analyzing multiple characteristics of biological particles, as well as the ability to rapidly isolate and purify cell populations of interest for the purpose of assessing immunological function and molecular distinctions, cell culture cloning, and animal transplantation studies. The FCCF is staffed with highly trained instrument specialists with a combined 21 years of researchbased flow cytometry experience. The facility houses five benchtop analyzers, two high-speed cell sorters, a bead array analyzer, an automated bead sorter, and a fluorescent microscope. The FCCF provides several services including multi-parameter analysis, cell sorting, data analysis and graphics programs, instrument training, project consultation, flow cytometry courses, and application workshops. It also houses a current literature base including cytometry journals and textbooks;vendor information on instrumentation, reagents, and services;and handbooks on flow cytometry-based methodology, procedures and techniques. Overall usage in the FCCF has increased more than 180% since the 2000 CCSG submission as a result of investigator recruitment, increased instrument capacity, and the initiative to train users to operate the benchtop cytometers, which allows them unlimited independent access. Over 39 peer-reviewed investigators across all research programs routinely access the FCCF, totaling 88% usage of acquisition service, 85% usage for cell sorting, and 80% of service training. Usage is expected to grow with investigator recruitment over the next few years. The Core Facility provides critical support for the scientific programs at the Cancer Center by giving investigators access to state-of-the-art instrumentation, cutting-edge cytometry applications, and exceptionally trained staff committed to contributing to outstanding scientific research efforts to understand and control cancer biology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-13
Application #
8214129
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-02-01
Budget End
2012-01-31
Support Year
13
Fiscal Year
2011
Total Cost
$131,025
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Reed, Damon R; Mascarenhas, Leo; Manning, Kathleen et al. (2016) Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies. Cancer Med 5:294-303
Permuth, Jennifer B; Pirie, Ailith; Ann Chen, Y et al. (2016) Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet 25:3600-3612
Weber, Jeffrey; Gibney, Geoffrey; Kudchadkar, Ragini et al. (2016) Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab. Cancer Immunol Res 4:345-53
Schabath, Matthew B; Massion, Pierre P; Thompson, Zachary J et al. (2016) Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. PLoS One 11:e0159880
Turner, Joel G; Dawson, Jana L; Grant, Steven et al. (2016) Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors. J Hematol Oncol 9:73
Haake, Scott M; Li, Jiannong; Bai, Yun et al. (2016) Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics. Clin Cancer Res :
Extermann, Martine; Leeuwenburgh, Christiaan; Samiian, Laila et al. (2016) Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. J Geriatr Oncol :
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2016) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol :
Kim, Jae-Young; Welsh, Eric A; Fang, Bin et al. (2016) Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer. Mol Cancer Res 14:1019-1029
Robinson, Lary A; Jaing, Crystal J; Pierce Campbell, Christine et al. (2016) Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br J Cancer 115:497-504

Showing the most recent 10 out of 974 publications